Reetika Bhardwaj
Associate at ARCH Venture Partners
Greater Chicago Area
Overview
Work Experience
Senior Associate
2019 - Current
Associate 2020-2022 Senior Associate 2023-now - Dedicated to company building and direct investing into disruptive life sciences companies across indications, technologies, and modalities -Source and evaluate investment opportunities across biotech and life sciences that have signifcant impact on human health -Create new ventures and operate within portfolio companies. Investments: Pretzel, AIRNA, Moleculent, Protillion, Metsera, KoreAx, Cytrellis Operations: Walden, Tenvie, Cytrellis, Pretzel
ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Board Observer
2021
-Investment and company formation of Pretzel -Business development, Competitive intelligence
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Raised $72,500,000.00 from University of Cambridge Enterprise, Karolinska, Google Ventures, Mubadala Capital Ventures, Angelini Ventures, Invus, EIR Ventures, HealthCap, ARCH Venture Partners and GU Ventures.
Board Observer
2022
-Direct Investment, syndicate formation -Business development, strategy, operations, competitive intelligence, and chief of staff duties for early stage RNA editing company, from seed through Series B -Indication selection, TPP
Board Observer
2024
- Direct investment - Portfolio support
Board Observer
2023
Protillion Biosciences specializes in the design and development of protein-based drugs.
Raised $18,000,000.00 from Illumina Ventures and ARCH Venture Partners.
Board Member
2021
- Investor relations -Commercial operations and strategy
Innovation Fund Associate
2019 - 2020
• Perform due diligence on a Sleep disorder therapeutics and a pediatric insomnia device company; analyzing potential market, reviewing technology, and assessing development milestone • Advised advisory committee to invest $250K per startup from a $20 M seed fund ; the companies were successfully funded • Served in a venture capital associate role in order to equip the Shultz Innovation Fund Advisory Committee to make investment decisions
UChicagoTech launched the Innovation Fund in 2010 to accelerate the commercialization of promising.
Investment Banking Associate (M&A)
2019 - 2019
Credit Suisse Group is a financial services company that advises clients in all aspects of finance.
I-Corp Fellow
2018 - 2019
Business Development Lead for early stage startups in the field of Neuroscience- Alzheimer and Sleep Apnea
Scientific Advisor and Business Development
2015 - 2018
Spectrums unique business approach is working our clients know it, our veteran and newly hired team members.